Vastin 10 mg (Tablet)

Unit Price: ৳ 8.03 (20's pack: ৳ 160.60)

Medicine Details

Category Details
Generic Atorvastatin calcium
Company Amico laboratories ltd

Title

  • Vastin 10mg Tablet

Category

  • Medicine
  • Pharmaceutical
  • Health

Description

  • Vastin 10mg Tablet is indicated as an adjunct to reduce elevated total cholesterol, LDL cholesterol, apolipoprotein B (Apo-B) and triglycerides levels in various diseases, in conjunction with diet and other non-pharmacological measures.

Primary Use

  • Reduction of total cholesterol and LDL cholesterol
  • Treatment of mixed dyslipidemia
  • Prevention of cardiovascular events
  • Reduction of cardiac ischaemic events
  • Hypercholesterolemia associated with diabetes mellitus or renal transplantation
  • Adjunct to diet in familial hypercholesterolemia

Mode of Action

  • Selective inhibitor of HMG-CoA reductase
  • Lowers plasma cholesterol and lipoprotein levels
  • Increases hepatic LDL receptors for enhanced uptake and catabolism of LDL

Absorption

  • Rapidly absorbed after oral administration
  • Maximum plasma concentrations occur within 1 to 2 hours

Distribution

  • Mean volume of distribution is approximately 381 liters
  • 98% bound to plasma proteins

Metabolism

  • Extensively metabolized to ortho- and parahydroxylated derivatives and various beta-oxidation products
  • In vitro studies suggest importance of metabolism by cytochrome P450 3A4

Excretion

  • Eliminated primarily in bile following hepatic and/or extra-hepatic metabolism
  • Mean plasma elimination half-life is approximately 14 hours

Dosage & Administration

  • Recommended starting dose of 10 or 20 mg once daily
  • Doses should be individualized according to recommended goal of therapy
  • Can be administered as a single dose at any time of the day, with or without food
  • Adjustments should be made at intervals of 4 weeks or more

Interactions

  • Increased risk of myopathy with concurrent administration of certain drugs
  • Plasma concentrations altered when coadministered with antacid, colestipol, digoxin, erythromycin, oral contraceptives, warfarin

Contraindications

  • Hypersensitivity to any component of this medication
  • Active liver disease or unexplained persistent elevations of serum transaminases
  • History of serious adverse reaction to prior administration of HMG-CoA reductase inhibitors

Side Effects

  • Most frequent side effects include constipation, flatulence, dyspepsia, abdominal pain
  • Other side effects include infection, headache, back pain, rash, asthenia, arthralgia, myalgia

Pregnancy & Lactation

  • Contraindicated during pregnancy
  • Not known whether it's excreted in human milk
  • Maternal treatment may reduce fetal levels of mevalonate
  • Safety in pregnant women not established

Precautions & Warnings

  • Liver function tests should be performed before initiation of treatment and periodically thereafter
  • Discontinue therapy if markedly elevated CPK levels occur or myopathy is diagnosed or suspected

Use in Special Populations

  • Plasma concentrations higher in healthy elderly subjects
  • No clinically significant difference in LDL-C reduction between men and women
  • Renal disease has no influence on plasma concentrations or LDL-C reduction
  • Hemodialysis not expected to significantly enhance clearance

Overdose Effects

  • Specific treatment not available
  • Patient should be treated symptomatically and supportive measures instituted
  • Liver function tests should be performed and serum CK levels monitored

Therapeutic Class

  • Other Anti-anginal & Anti-ischaemic drugs
  • Statins

Storage Conditions

  • Keep in a dry place away from light and heat
  • Keep out of the reach of children

Chemical Structure

  • Molecular Formula: C33H35FN2O5
  • Chemical Structure Image: Link to chemical structure image

Common Questions

  • What is Vastin 10 mg Tablet?
  • How should I take Vastin 10 mg Tablet?
  • What are the uses of Vastin 10 mg Tablet?
  • What are the Side Effects of Vastin 10 mg Tablet?
  • What are the instructions for storage and disposal of Vastin 10 mg Tablet?
  • Is Vastin 10 mg Tablet used for lowering cholesterol?
  • Will taking Vastin 10 mg Tablet increase my risk of diabetes?
  • For how long do I need to take Vastin 10 mg Tablet? Is it safe for long-term use?
  • Does Vastin 10 mg Tablet cause weight loss?
  • Can I stop taking Vastin 10 mg Tablet?
  • Does Vastin 10 mg Tablet cause memory loss?
  • Does Vastin 10 mg Tablet make you tired?
  • Can Vastin 10 mg Tablet be prescribed to children?
  • Is Vastin 10 mg Tablet a blood thinner?
  • Quick Tips for taking Vastin 10 mg Tablet

Indications

  • Indicated as an adjunct to diet to reduce elevated total cholesterol, LDL cholesterol, apolipoprotein B and triglycerides levels
  • For various diseases when response to diet and other non-pharmacological measures is inadequate

Blood Test Monitoring

  • Liver function tests should be performed before initiation of treatment and periodically thereafter

Associated Risks

  • Increased risk of myopathy with concurrent administration of certain drugs
  • Potential adverse reactions in pregnant women and during lactation

Maximum Dosage

  • Maximum dosage of 80 mg once daily for adults

Molecular Weight

  • Approximately 558.65 g/mol

Tolerability

  • Generally well-tolerated

Bioavailability

  • Approximately 14% for Atorvastatin (parent drug)
  • Approximately 30% for systemic availability of HMG-CoA reductase inhibitory activity

Plasma Protein Binding

  • 98% bound to plasma proteins

AUC Values

  • AUC values for norethindrone and ethinyl estradiol increased by approximately 30% and 20% when coadministered with an oral contraceptive

Drug Food Interaction

  • Can be taken with or without food

Pediatric Use

  • Recommended starting dose of 10 mg/day for pediatric patients aged 10-17 years

Elderly Population

  • Plasma concentrations are higher in elderly subjects compared to young adults

Hepatic Insufficiency

  • Plasma concentrations are markedly increased in patients with chronic alcoholic liver disease

Special Populations

  • Pharmacokinetic data not available for the pediatric population

Niacin Interaction

  • Increased risk of myopathy with concurrent administration of niacin

Cyclosporine Interaction

  • Increased risk of myopathy with concurrent administration of cyclosporine

Fibric Acid Derivatives Interaction

  • Increased risk of myopathy with concurrent administration of fibric acid derivatives

Molecular Structure

  • Chemical structure consists of C, H, F, N, and O atoms in specific proportions

Supportive Measures

  • Supportive measures should be instituted for atorvastatin overdose

Elimination half-life

  • Approximately 14 hours in humans

Potential Side Effects

  • May include constipation, flatulence, dyspepsia, abdominal pain, infection, headache, back pain, rash, asthenia, arthralgia, myalgia

Preventive Use

  • Prevention of heart attacks
  • Prevention of cardiovascular events

Biochemical Pathway

  • Selective inhibition of HMG-CoA reductase enzyme

Avoidable Interactions

  • Avoid concurrent administration with drugs that increase the risk of myopathy

Disposition

  • Primarily eliminated in bile following hepatic and/or extra-hepatic metabolism

Plasma Levels Monitoring

  • Steady-state plasma digoxin concentrations increased by approximately 20% with coadministration of atorvastatin and digoxin

Known Allergies

  • Hypersensitivity to any component of this medication

Anion-exchange Resin Use

  • May be combined with anion-exchange resin in heterozygous familial hypercholesterolaemia

Selective Inhibition

  • Selective inhibition of HMG-CoA reductase

Pediatric Dose Adjustment

  • Recommended starting dose of 10 mg once daily for children aged 10-18 years

Severity of Adverse Effects

  • Serious adverse reaction to prior administration of HMG-CoA reductase inhibitors reported

Dose Adjustment

  • Dose should be adjusted according to response

Dose Range

  • Dosage range of 10 to 80 mg once daily

Medication Planning

  • After initiation, lipid levels should be analyzed within 2 to 4 weeks and dosage adjusted accordingly

Teratogenic Effects

  • Rare reports of congenital anomalies following intrauterine exposure to HMG-CoA reductase inhibitors

Xenobiotic Metabolism

  • Extensive metabolism to ortho- and parahydroxylated derivatives and various beta-oxidation products

Related Brands